ABSI Competitors & Alternatives
Compare Absci Corp with similar stocks in the same industry
Biotechnology
ABSI
Main Stock$8.32
Tradestie Score
52
Market Cap
$468.01M
Revenue Growth
-0.8%
Analyst Upside
+65.6%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$18.50
|
$1.49B | - | 58 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$29.48
|
$1.43B | - | 50 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$16.26
|
$1.42B | - | 54 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$22.64
|
$1.35B | - | 58 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$42.56
|
$1.32B | - | 54 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$8.78
|
$1.29B | 125.7 | 56 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$28.81
|
$1.29B | - | 59 | Compare |
|
ARDX
Ardelyx, Inc.
|
$5.09
|
$1.29B | - | 58 | Compare |
|
ZYME
Zymeworks Inc.
|
$24.05
|
$1.28B | - | 53 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$6.43
|
$1.27B | - | 55 | Compare |
More ABSI Analysis
Data updated: Jul 21, 2026 | Industry: Biotechnology (SIC 8731)
227 stocks in this industry